BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
QNRX upcoming catalysts
Quoin Pharmaceuticals: 3 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (3 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 1 readout(s) and 0 FDA event(s). Subscribe to QNRX (.ics).
Drugs: QRX003, 4% Lotion, QRX003
Upcoming FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| No upcoming PDUFA date or AdCom found. | |||||
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-12-30 est. | P2/P3 | Quoin Pharmaceuticals QNRX | NCT05789056 Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome | Netherton Syndrome | recruiting | 20 |
| 2026-12-30 est. | P2/P3 | Quoin Pharmaceuticals QNRX | NCT06953466 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome | Netherton Syndrome | recruiting | 8 |
| 2027-01-31 est. | P2/P3 | Quoin Pharmaceuticals QNRX | NCT07538583 Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome | Netherton Syndrome | recruiting | 16 |
FDA decision events, last 12 months
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| No FDA decision events in this window. | |||||
Trial readouts, last 12 months
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2025-12-30 | P2/P3 | Quoin Pharmaceuticals QNRX | NCT05521438 Safety, Tolerability and Efficacy of QRX003 Lotion in Subjects With Netherton Syndrome | Netherton Syndrome | active not recruiting | 30 |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.